Navigation Links
Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
Date:12/18/2013

SOUTH PLAINFIELD, N.J., Dec. 18, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company dedicated to developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and mortality, today announced the addition of Ronald G. Jubin, Ph.D. to their executive team as Managing Director, Research and Development. In his new role, Dr. Jubin will be responsible for pre-clinical discovery, methods development and the advancement of Prolong's pipeline candidates.

(Logo:  http://photos.prnewswire.com/prnh/20130926/NY87531LOGO )

"Ron brings more than two decades of experience at the forefront of drug discovery to our efforts here at Prolong," said Dr. Abraham Abuchowski, Prolong's Chief Scientific Officer and CEO. "We are excited to bring him on board at this important time in our company history." In October, Prolong presented Phase I data for its flagship product SANGUINATE an intravenous therapeutic that combines the beneficial functions of a carbon monoxide releasing molecule with an oxygen transfer agent as well as acting as a plasma expander. SANGUINATE was found to be well tolerated with no serious adverse events, and is now moving forward into Phase II trials in patients with sickle cell disease who suffer from painful vaso-occlusive crises. 

Dr. Jubin's experience includes key roles at Schering-Plough Research Institute and PBL Biomedical labs. At Schering-Plough, he served in major roles in the hepatitis C protease program, directed other HCV inhibitor programs and managed internal committees evaluating novel interferon candidate licensing opportunities. At PBL Biomedical, his tenure leading the R&D department at PBL resulted in the development of numerous interferon proteins
'/>"/>

SOURCE Prolong Pharmaceuticals LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Prolong TM, a New Revolutionary First Line Treatment for Premature Ejaculation is Licensed in Europe
3. Prolong Pharmaceuticals Presents Novel Multi-Pronged Approach To Treating Sickle Cell Disease At The SCDAA Meeting
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  Lockton Dunning Benefits, the Dallas ... addition of Vice President Kim Foerster ... Consulting team, Excelsior Solutions. Foerster ... the position.  Most recently, she worked as the ... Pharmacy, where she has held various managerial positions ...
(Date:12/24/2014)... and RALEIGH, N.C. , ... of Endo International plc (NASDAQ: ENDP ) ... BDSI ) announced today that they have submitted ... Film to the U.S. Food and Drug Administration (FDA).  ... management of pain severe enough to require daily, around-the-clock, ...
(Date:12/22/2014)... Calif. , Dec. 22, 2014 Apnea ... expanded corporate offices in Aliso Viejo ... that due to the tremendous growth and worldwide expansion, ... Sales of patented SnoreRx, the anti snore cure have ... He said, "We are now in 23 countries ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... LEUVEN, Belgium, June 25 , ... for the,Non-Surgical Treatment of Eye Disease With No Reported Safety ... THR), a biotechnology company,focused on the discovery and development of ... that its lead product,microplasmin, which is in Phase III trials ...
... personalized chemotherapy can improve cure rate and avoid the ... , , MEMPHIS, Tenn., June 24 ... treated using a carefully personalized chemotherapy regimen without cranial ... found. Such radiation of the brain was once a ...
Cached Medicine Technology:ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 2ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule 3Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 3Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 4
(Date:12/25/2014)... (PRWEB) December 26, 2014 This is ... of the global Sterilizers industry with a focus on ... the market status of the Sterilizers manufacturers and is ... and individuals interested in the industry. This report provides ... applications and manufacturing technology. In this part, the report ...
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
(Date:12/25/2014)... York (PRWEB) December 25, 2014 Product ... DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to ... According to an Order issued in the U.S. District ... Court will convene an open conference on January 7, ... United States Courthouse in West Palm Beach, Florida. The ...
(Date:12/25/2014)... 26, 2014 Recently, iFitDress.com, the popular online ... has announced its new selection of black one-shoulder cocktail ... sale now; they are available at discounted prices, up to ... promotion will last for three weeks only. You know, we ... who are interested in our new items can visit our ...
(Date:12/25/2014)... CA (PRWEB) December 25, 2014 The short ... was created in honor of a true 9/11 hero, ... two film festivals including the 24 hours of Nuremberg International ... in Bangladesh. , Actress, screenwriter and director Luciana ... produce this film together with her husband, Gregory Graham ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... 5 MRSA Survivors Network, the prominent advocacy group ... and the official web site, www.worldmrsaday.org ... governments, the healthcare industry and the community for a ... the globe at an alarming rate.MRSA Survivors Network, the ...
... to Give Voice to Improving Quality Care and Quality Careers ... software for better senior living, celebrates National Nurse Week May ... about how to improve the business, the quality of care ... care. Vigilan is offering an online and phone-based survey ...
... Cellular Therapy (ISCT) Demonstrating Potential to Expand Cord ... Fla., May 5 /PRNewswire-FirstCall/ -- Cryo-Cell ... showing that adding menstrual blood stem cells (MenSCs) ... the number of progenitor cells (cells that grow ...
... Triple-S Management Corporation (NYSE: GTS ), the ... revenues of $473.9 million and operating income of $11.1 million ... of $3.9 million, or $0.13 per diluted share, includes an ... share in net realized and unrealized losses on investments and ...
... Customers Ultimate Economy-Friendly FinancingMIAMI, May 5 In ... open doors for promising opportunities that arise out ... of such prospects is the unprecedented offer Lasik ... ("VISO"), presents its clientele nation-wide with their VISO ...
... adds a fun, playful pop of whimsy to any ... support disabled artists seeking financial independenceSANTA CLARA, Calif., May ... ( www.AOPStudios.com ), the only art brand exclusively representing ... it has finalized a licensing agreement with ...
Cached Medicine News:Health News:MRSA Activists Rally For World MRSA Day 2Health News:Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care 2Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 2Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 3Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 4Health News:Menstrual Blood Stem Cells May Significantly Increase Yield of Cord Blood Stem Cells 5Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 2Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 3Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 4Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 5Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 6Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 7Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 8Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 9Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 10Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 11Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 12Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 13Health News:Triple-S Management Corporation Reports First Quarter 2009 Results 14Health News:Financial Advantage in Plummeting Economy: Lasik Eye Surgery Provides More Than the Advantage of Clear Vision 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 2Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 3Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 4Health News:Playing with Fashion: New 'Phenominoes' Pendants Feature Blind Artists' Phenomenal Artwork on Real Dominoes 5
... Brachytherapy Seed Sterilization and Sorting Tray is designed ... separate wells. Seeds can also be sorted according ... a number for identification and can easily hold ... in diameter so it will easily fit into ...
... needles for use with Mick® ... needles used to facilitate transperineal, ... needle has an exceptionally sharp ... an echogenic tip for easy ...
... ACMI™ offers five classes of resectoscope ... cutting loops, knife, roller bar & ... the only electrodes specifically integrated into ... tissue removal with minimal bleeding, increased ...
ACMI™ S-Series Resectoscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
Medicine Products: